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Abstract 
Background: Type 2 diabetes includes a series of disorders characterized by hyperglycemia, which are followed by 
dysfunction in insulin secretion. In the clinical laboratory, A1C test defines blood glucose levels over a three-month 
period. The aim of this study is to evaluate the correlation between HbA1c and hyperlipidemia in patients with type 
2 diabetes. Materials and Methods: An cross-sectional study was performed on 209 diabetic patients men (n=109) 
and women (n=100) with a mean age of 57.1 ± 11.1 years. Diagnosis of diabetes was performed according to the 
WHO criteria. In this study, venous blood (5 ml) was collected from participants after overnight fasting, and HbA1C 
levels and lipid profiles were determined using enzymatic methods and auto-analyzer device. Risk factor values 
(TCH/HDL-C) and atherogenic index of plasma (AIP) (logTG/HDL-c), as well as LDL-C/HDL-C ratio, were 
calculated. Results: HDL-C and TCH / HDL-C were significantly increased in women. On the other hand, LDL-
C/HDL-C and HbA1c levels were significantly higher in men. There was no significant difference in the levels of 
cholesterol, triglyceride, fast blood sugar (FBS), LDL-C, and AIP between women and men. Cholesterol, FBS, LDL-
C and LDL-C/HDL-C also showed a significant direct correlation with HbA1c, but no significant correlation was 
observed between triglyceride, HDL, AIP, and risk ratio with HbA1c. Conclusion: HbA1c may be considered as a 
biomarker for dyslipidemia screening in patients with type 2 diabetes. 
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Diabetes is one of the most significant 
diseases in the U.S. and is one of the problems of 
today's human societies(1). Diabetes mellitus (DM) 
is a metabolic syndrome caused by defects in 
secretion or dysfunction of insulin(2). Oscillations of 
lipid profiles occur as a result of DM and due to 
these alterations, distribution and function of various 
lipids are affected (3). Type 2 diabetes (T2DM) is a 
complex condition with low levels of HDL-C and 
increased levels of triglycerides and LDL-C. These 
are the main features of insulin resistance syndrome, 
which is seen in most patients with diabetes. In fact, 
individuals predisposed to diabetes have shown high 
levels of lipid profiles such as cholesterol, 
triglycerides, LDL-C, and low levels of HDL-C(4) 
World Health Organization (WHO) investigations 
estimate that the number of patients with diabetes has 
risen from 135 million in 1995 to 300 million in 2025 . 
According to the International Federation of Diabetes 
(IDF) in 2013, more than 3.4 million people were 
diagnosed with diabetes in Iran and the prevalence in 
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adults of 20-79 years was 43.8%. In addition, about 
38002 individuals died from diabetes and up to the 
now, approximately 2198 patients with diabetes in 
Iran have not been statistically diagnosed(5). 
Hemoglobin A1C (HbA1c) is an important indicator 
of long-term glycemic control over a period of two to 
three months and is extensively used for treatment 
decisions in clinics(6). Hb Glycation, the 
incorporation of non-enzymatic glucose into the 
amino group of protein is irreversible and is 
correlated with Hb lifespan and blood glucose 
concentration. This measurement indicates blood 
glucose levels over the last 6-8 weeks(7). There is a 
direct correlation between HbA1c and diabetes 
complications(8). Coronary artery disease (CAD) is 
one of the major reasons for mortality in patients 
with non-insulin dependent diabetes (NIDDM)(9). In 
several experiments, the risk factors for CAD in 
patients with diabetes were specified and increased 
levels of total cholesterol, LDL-C, VLDL-C, and 
HDL-C were decreased compared to controls(1). 
Previous studies have shown that HbA1c level can 
not only be used as a long-term indicator of blood 
glucose but also as a high level of HbA1c with an 
increased risk of cardiovascular disease and 
mortality(10). 
Therefore, continuous monitoring of HbA1C 
in patients with diabetes as well as consumption of 
glucose-lowering drugs can improve the risk of 
complications regarding hyperglycemic control(11). 
It is also recommended that HbA1c and glycemic 
control should be evaluated every 3 to 6 months(12). 
Today, the key target in the treatment of patients with 
diabetes is to achieve a level of less than 7% (optimal 
control) since it is linked to reduced mortality(13). 
According to the aforementioned points, proper 
glycemic and lipid profile control in patients with 
diabetes can lead to a dramatic improvement of 
awareness and reduce the cost of treatment. In this 
study, we investigated a group of patients with 
T2DM who referred to Bouali hospital in Sari to 
evaluate serum lipids , HbA1c levels, and the 
possible correlation among them. Furthermore, the 
association of atherogenic index of plasma (AIP) 
with HbA1C and risk ratio (TCH / HDL-C) were 
investigated. 
Methods 
This analytical cross-sectional study was 
conducted from February 23 to May 31, 2018, at 
Bouali Hospital with the approval of the Ethics 
Committee of Mazandaran University of Medical 
Sciences. All necessary information in patients’ 
profiles was employed considering Ethical Principles 
of Helsinki, and on the basis of non-probability 
sampling. 209 patients with diabetes, including men 
(n=109) and women (n=100), were selected. Diagnosis 
of diabetes was performed according to WHO criteria. 
Accordingly, a fasting blood glucose level of ≥126 
mg/dL or 2 hours glucose (2hPG) ≥196 mg/dL was 
indicative of diabetes. Cases did not use alternative 
therapies with hormone or vitamin supplements. 
Moreover, patients consuming tobacco and alcohol, as 
well as cases of the following conditions were 
excluded from the study: chronic diseases of kidney, 
liver, and lung; acute inflammatory diseases 
(especially acute pancreatic and endocarditis 
infections); heart valve disease; short stomach allergy 
syndrome; immunodeficiency; pregnancy and lactating 
women. Blood samples were collected and the levels 
of HbA1C, HDL-C, LDL-C, TCH, and TG were 
determined using enzymatic methods (Auto-analyzer). 
Eventually, the values of the ratio of LDL-C/HDL-C 
and the risk ratio of TCH/HDL-C as well as 
Atherogenic Index of Plasma (AIP) were calculated. 
To compare the mean of two or more groups, t-test 
and ANOVA were used respectively. Furthermore, 
Pearson correlation test was used to examine the linear 
correlation of variables. All tests and statistical 
analyses were performed using SPSS16 software. 
Results 
The mean age for all people was 57.1 ± 11.1 
years. The average was 56.1 ± 9.9 for women and 58.1 
± 11.8 years for men. There was no significant 
difference in the mean age between men and women 
(P> 0.05). The mean HbA1C level and lipid profiles of 
men and women, as well as the total mean of patients, 
are shown in Table 1. The level of HDL-C (P <0.001), 
TCH/HDL-C (P = 0.011), LDL/HDL (P = 0.015) and 
HbA1C (P = 0.053) in both groups of men and women 
with diabetes were significantly different. 
Nevertheless, there was no statistically significant 
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difference in mean age, cholesterol, triglyceride, 
FBS, LDL-C and AIP between men and women (P> 
0.05). 
The relationship between HbA1C and lipid 
profiles demonstrates that among lipid factors, 
cholesterol level (p = 0.005) is directly correlated 
with HbA1C. Moreover, there was a direct 
correlation between LDL-C (p <0.001), LDL-
C/HDL-C (p <0.001), and FBS (p <0.001) with 
HbA1C. However, there was no direct significant 
correlation between triglyceride, HDL, AIP, and risk 
ratio with HbA1c (P> 0/05) (Table 2). 
 
Discussion 
T2DM is a fundamental dilemma all over the 
world and is strongly associated with obesity. Due to 
hyperglycemia and insulin resistance 
syndrome.Moreover, patients with T2DM encounter a 
high risk for development of a wide range of 
microvascular disorders including neuropathy, 
retinopathy, and nephropathy as well as macrovascular 
problems affecting the cardiovascular system. T2DM 
is a multifactorial disorder with an etiological basis of 
environmental and genetic factors. Main complications 
resulted by T2DM include insulin resistance and 
complications of insulin secretion. In spite of this, 
there are other pathophysiological abnormalities that 
lead to deregulated metabolism of glucose(15).  
In patients with T2DM, low levels of HDL-C 
and high levels of triglycerides and LDL-C are 
observed. In fact, this profile characterizes patients 
with insulin resistance syndrome, a case demonstrated 
in most patients with diabetes. Moreover, individuals 
who are prone to diabetes are reported with high levels 
of cholesterol, triglycerides, LDL-C, and low levels of 
HDL-C(4). 
In this study, the correlation of HbA1c and 
hyperlipidemia was analyzed in T2DM patients. Our 
findings show a significant correlation between 
HbA1C levels and lipid factors including TCH, LDL-
C, and LDL-C/HDL-C. However, there was no 
Table2. Association of HbA1C with lipid factors. 
HbA1C  
p-value Pearson-Correlation  
<.001** .77* FBS(mg/dl) 
.005** .19* TCH(mg/dl) 
.22 .08 TG(mg/dl) 
.52 .05 HDL-C(mg/dl) 
.001** .22* LDL-C(mg/dl) 
.68 .03 Risk Ratio 
.06 -.12 AIP 
<.001** .24* LDL-C/HDL-C 
*Correlation is significant at .01 




(Mean  ± SD) 
T-Test 
Male 
(Mean ± SD) 
Female 




95% CI of the 
Difference 
Lower Upper 
HbA1C 9.4 ± 1.8 9.1 ± 1.5 9.2 ± 1.7 1.9 .053* .5 -.1 .9 
Age (years) 58.1 ± 11.8 56.1 ± 9.9 57.1 ± 11.1 1.3 0.17 2.1 -.9 5.1 
FBS(mg/dl) 184.9 ± 70.8 179.3 ± 67.5 182.2 ± 69.2 0.6 .55 5.6 -13.3 24.5 
TCH(mg/dl) 176.4 ± 42.9 184.9 ± 41.8 180.4 ± 42.5 -1.4 .15 -8.4 -20.1 3.1 
TG(mg/dl) 183.2 ± 117.0 183.1 ± 82.6 183.2 ± 101.8 .01 .99 .2 -27.7 28.1 
HDL-C(mg/dl) 47.1 ± 9.8 52.5 ± 10.1 49.6 ± 10.3 -3.9 <.001*** -5.3 -8.1 -2.6 
LDL-C(mg/dl) 94.2 ± 27.6 97.8 ± 26.9 95.9 ± 27.3 -.9 .34 -3.6 -11.1 3.8 
Risk Ratio 3.5± .5 3.8 ± 0.6 3.6 ± .6 -2.5 .011** -.2 -.4 -.1 
AIP .52 ± .39 .55 ± .21 .54 ± .32 -.7 .45 -.03 -.12 .05 
LDL/HDL 2.1 ± 0.4 1.8 ± 0.4 1.9 ± .41 2.5 .015** .1 .1 .3 
Significant with *p<0.1, **p<0.05, ***p<0.01 
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significant correlation between HbA1C and HDL-C, 
TG, risk ratio and AIP. There was a significant 
difference between TCH/HDL-C, HDL-C, LDL-
C/HDL-C and HbA1C in men and women. HDL-C 
and TCH/HDL-C levels were significantly higher in 
women than in men, and LDL-C/HDL-C and HbA1c 
levels were significantly higher in men. However, 
Wechsler(16) reported that the levels of TC and 
LDL-C were higher in women than men. This study 
showed that high occurrence of dyslipidemia could 
be a warning sign for cardiovascular disease. There 
was also a significant relationship between TC, and 
LDL-C with HbA1c. In several studies on patients 
with diabetes, a positive correlation was observed 
between HbA1c and TC, LDL-C, and TG(17, 18). 
Similarly, the association between HbA1c and FBG 
was similar to that in previous studies(19). 
Considering the results obtained in this study, it is 
suggested that HbA1c might be an indicator of long-
term glucose control, and due to being directly 
correlated with lipid-like risk factors such as TCH, 
LDL-C and LDL/HDL, it might serve as a risk factor 
for cardiovascular disease as well as an index of 
increased levels of lipid factors in diabetic patients. 
Notwithstanding, there was no significant correlation 
found between AIP and risk ratio. Therefore, further 
research is needed to clarify the accuracy of this 
hypothesis. 
The results of the current study are consistent 
with the results reported by Smatha et al in India. 
who examined the association between HbA1c and 
lipid profiles in patients with diabetes. Cases with an 
HbA1C level of >7% indicated a direct and 
significant correlation between this factor and TCH, 
LDL-C, and LDL-C/HDL-C. However, no difference 
in the levels of TG and HDL-C was observed 
between the two groups(20).  
The study of Arshad et al. on  patients with 
diabetes mellitus in Afghanistan showed a positive 
correlation between HbA1c and cholesterol, TG, 
LDL-C and LDL-C / HDL-C. However, no 
correlation was found between HDL-C and HbA1c. 
No significant change in the levels of TG, HDL-C, 
TCH, LDL-C and TCH/HDL-C was observed 
between the two groups(21). The results of our study 
are similar to the results reported by Arshad et al. In 
spite of this, a significant difference was observed in 
the levels of HDL-C and TCH/ HDL-C between the 
two groups in our study. This inconsistency might be 
due to the small sample size analyzed in our study. 
In another study by Rajul and colleagues in 
2016, the association between HbA1C and lipid 
profiles was evaluated. The levels of cholesterol, TG, 
HDL-C, LDL-C, and HbA1C were significantly higher 
in patients compared to controls. Furthermore, HbA1C 
was positively correlated with cholesterol, TG, LDL-C 
and negatively correlated with HDL-C(22). The 
contradictory results in our studies are likely due to 
low sample size and needs to be further investigated 
on a larger sample size. 
Our results are consistent with the results of the 
following studies; Bodhe et al. performed a study on 
HbA1c as a predictor of dyslipidemia and 
atherogenicity in diabetes mellitus in India. They 
reported a direct correlation between HbA1C and TG, 
LDL-C, and AIP. No correlation was observed 
between HbA1C with TCH and HDL-C(23). In 
another study by Abedian on patients affected with 
diabetes, TG levels were higher in men and HDL-C 
levels were higher in women. HbA1c was directly 
correlated with LDL-C, AIP, TG, TCH and risk ratio, 
but not correlated with age, HDL-C/LDL-C and HDL-
C(24). Although the findings of our study are similar 
to those reported by these studies, our results on AIP 
and HDL-C show inconsistency compared to the 
results of these studies. Since both studies were 
performed on a small sample size, further research on 
a larger sample size is required. 
The study of Khan H.A et al in 2006 in India 
revealed a direct correlation between HbA1C and 
cholesterol, TG, and LDL, as well as an inverse 
correlation with HDL-C. Our results were consistent 
except for TG. Considering the sample size, the results 
of TG are more reliable(25). 
Based on our results as well as the findings of 
other studies, there was a correlation between HbA1C 
and cardiovascular risk factors such as TCH, LDL-C, 
and LDL/HDL. Besides being a potential risk factor in 
cardiovascular disease, HbA1c could be used as a 
long-term indicator of blood glucose. However, further 
research is required to elucidate the status of risk ratio 
and AIP regarding the contradictory findings. This 
study is advantageous because little data is available 
and  few studies were dedicated to the analysis of risk 
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ratio and AIP. In addition, the results of the risk ratio 
and AIP in our study are in contradiction with the 
results of previous studies. Moreover, our study 
presents highly reliable data. However, it is limited 
by small sample size and lack of personal 
information on whether individuals have consumed 
drugs. Further studies on larger samples with 
available medical records and medication outcome 
on people with diabetes are required in order to 
obtain more accurate and complete information on 
HbA1C and lipid profiles as well as its correlation 
with cardiovascular complications.  
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